glp-1 analogues market Long-Acting Size, Trends, Growth Report 2033 Glucagon Like Peptide-1 (GLP-1) Agonists

Gastrointestinal effects are the most frequent side effects, with rates varying by medication and dose

Early and honest conversations like these promote safety, trust, and shared decision-making from the outset of treatment

Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP

However, similar to other chronic diseases such as T2D, the focus in obesity management (including pharmacotherapy prescription) over time will need to be shifted to primary care and collaborative integrated care models to be developed between specialist obesity services and primary care striving to meet the needs of people living with obesity [115]

Simultaneously, these agents suppress glucagon secretion from pancreatic alpha cells, further helping to regulate blood glucose levels

This is also a good time for your first body composition assessment (DEXA scan or equivalent)